Dataset Information


Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors.

ABSTRACT: The potential for adoptive cell immunotherapy as a treatment against cancers has been demonstrated by the remarkable response in some patients with hematological malignancies using autologous T cells endowed with chimeric antigen receptors (CARs) specific for CD19. Clinical efficacy of CAR-T cell therapy for the treatment of solid tumors, however, is rare due to physical and biochemical factors. This review focuses on different aspects of multiple mechanisms of immunosuppression in solid tumors. We characterize the current state of CAR-modified T cell therapy and summarize the various strategies to combat the immunosuppressive microenvironment of solid tumors, with the aim of promoting T cell cytotoxicity and enhancing tumor cell eradication.


PROVIDER: S-EPMC5767005 | BioStudies | 2018-01-01


REPOSITORIES: biostudies

Similar Datasets

2016-01-01 | S-EPMC4849432 | BioStudies
2016-01-01 | S-EPMC4843171 | BioStudies
1000-01-01 | S-EPMC5444493 | BioStudies
2018-01-01 | S-EPMC5943172 | BioStudies
2018-01-01 | S-EPMC6300726 | BioStudies
2017-01-01 | S-EPMC5675490 | BioStudies
2013-01-01 | S-EPMC6322669 | BioStudies
2018-01-01 | S-EPMC6428197 | BioStudies
2017-01-01 | S-EPMC5608623 | BioStudies
2017-01-01 | S-EPMC5685771 | BioStudies